MER-101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MER-101, covering 2009-02-20 to 2009-02-20. Get the full timeline:
Most recent: Clinical Trial Update: Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients [Phase 2]